» Articles » PMID: 20233110

Epidemiology of Multiple Sclerosis in Europe: a Review

Overview
Publisher Informa Healthcare
Specialty Psychiatry
Date 2010 Mar 18
PMID 20233110
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is a progressive demyelinating and degenerative disease of the CNS with symptoms dependent on the type of the disease and the site of lesions. During the progression of the disease, symptoms become more permanent and progressive disability ensues. MS is a disease characterized by wide variations between patients, thus making categorization difficult. The aim of the current study was to review the existing epidemiological data of MS in Europe published during the last decade (2000-2009), using PubMed. Findings revealed an increasing incidence of MS during the last decade. Recent data indicate that latitude does not play a key role in determining the onset of the disease. MS has a significant impact on the quality of life for most patients over many years. The disease is twice as common in women than in men, and is at its peak in the most economically productive years of life. Pregnancy, postpartum status and vaccines may influence the onset and the course of the disease. Only one of the reviewed papers provides a view of progression from onset to death.

Citing Articles

Clinical characteristics and dynamics of disability progression in a cohort of patients with multiple sclerosis in Latvians.

Kalnina J, Trapina I, Sjakste N, Paramonova N Neurol Sci. 2024; 45(7):3347-3358.

PMID: 38393441 PMC: 11176098. DOI: 10.1007/s10072-024-07404-z.


Impact of the first Gulf war on multiple sclerosis risk in Kuwait: a quasi-experimental study.

Akhtar S, Al-Hashel J, Alroughani R BMC Neurol. 2023; 23(1):259.

PMID: 37407920 PMC: 10320913. DOI: 10.1186/s12883-023-03295-3.


The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study.

Maniscalco G, Scavone C, Mascolo A, Manzo V, Prestipino E, Guglielmi G J Clin Med. 2022; 11(22).

PMID: 36431332 PMC: 9692274. DOI: 10.3390/jcm11226855.


Toxic Air Pollutants and Their Effect on Multiple Sclerosis: A Review Study.

Mohammadi M, Zarea K, Hatamzadeh N, Salahshouri A, Sharhani A Front Public Health. 2022; 10:898043.

PMID: 35875044 PMC: 9299435. DOI: 10.3389/fpubh.2022.898043.


Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project.

Maniscalco G, Morra V, Florio C, Lus G, Tedeschi G, Cianfrani M Pharmaceuticals (Basel). 2020; 13(12).

PMID: 33333889 PMC: 7765255. DOI: 10.3390/ph13120466.